Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab.
Saved in:
| Title: | Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab. |
|---|---|
| Authors: | Wang Y; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., Bukkems LH; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., van Hasselt JGC; Leiden Academic of Drug research, Leiden, the Netherlands., Crombag MR; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Dumoulin D; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hendrikx JJMA; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands., Theelen W; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Hulle T; Department of Medical Oncology, Leiden University Medical Center, the Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, the Netherlands., Zwaveling J; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., Becker A; Department of Pulmonology, Amsterdam University Medical Center, the Netherlands., Hiltermann J; Department of Pulmonology, University of Groningen, University Medical Center Groningen, the Netherlands., Hendriks LEL; Department of Pulmonary Diseases, GROW - Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands., van Geel RMJM; Department of Clinical Pharmacy & Toxicology, NUTRIM Research Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, the Netherlands., van Geffen WH; Department of Pulmonology, Radboudumc, Nijmegen, the Netherlands., van den Heuvel M; Department of Pulmonology, University Medical Center Utrecht, the Netherlands., Oude Munnink TH; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands., Smit EF; Department of Pulmonology, Leiden University Medical Center, the Netherlands., Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands., Moes DJAR; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands. Electronic address: d.j.a.r.moes@lumc.nl., Ter Heine R; Department of Pharmacy, Pharmacology and Toxicology, Radboudumc, Nijmegen, the Netherlands. |
| Source: | European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2026 May 23; Vol. 243, pp. 116829. Date of Electronic Publication: 2026 May 23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42258995 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bukkems+LH%22">Bukkems LH</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Hasselt+JGC%22">van Hasselt JGC</searchLink>; Leiden Academic of Drug research, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Crombag+MR%22">Crombag MR</searchLink>; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Dumoulin+D%22">Dumoulin D</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hendrikx+JJMA%22">Hendrikx JJMA</searchLink>; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Theelen+W%22">Theelen W</searchLink>; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Hulle+T%22">van der Hulle T</searchLink>; Department of Medical Oncology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kapiteijn+E%22">Kapiteijn E</searchLink>; Department of Medical Oncology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zwaveling+J%22">Zwaveling J</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Becker+A%22">Becker A</searchLink>; Department of Pulmonology, Amsterdam University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hiltermann+J%22">Hiltermann J</searchLink>; Department of Pulmonology, University of Groningen, University Medical Center Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Hendriks+LEL%22">Hendriks LEL</searchLink>; Department of Pulmonary Diseases, GROW - Research Institute for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Geel+RMJM%22">van Geel RMJM</searchLink>; Department of Clinical Pharmacy & Toxicology, NUTRIM Research Institute of Nutrition and Translational Research in Metabolism, Maastricht University Medical Center+, Maastricht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Geffen+WH%22">van Geffen WH</searchLink>; Department of Pulmonology, Radboudumc, Nijmegen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Heuvel+M%22">van den Heuvel M</searchLink>; Department of Pulmonology, University Medical Center Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Oude+Munnink+TH%22">Oude Munnink TH</searchLink>; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Smit+EF%22">Smit EF</searchLink>; Department of Pulmonology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Guchelaar+HJ%22">Guchelaar HJ</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Moes+DJAR%22">Moes DJAR</searchLink>; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, the Netherlands. Electronic address: d.j.a.r.moes@lumc.nl.<br /><searchLink fieldCode="AU" term="%22Ter+Heine+R%22">Ter Heine R</searchLink>; Department of Pharmacy, Pharmacology and Toxicology, Radboudumc, Nijmegen, the Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229005373%22">European journal of cancer (Oxford, England : 1990)</searchLink> [Eur J Cancer] 2026 May 23; Vol. 243, pp. 116829. <i>Date of Electronic Publication: </i>2026 May 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9005373 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0852 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209598049%22">09598049 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42258995 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.ejca.2026.116829 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 116829 Titles: – TitleFull: Model-informed approaches to develop drug cost-saving dosing strategies for pembrolizumab. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Bukkems LH – PersonEntity: Name: NameFull: van Hasselt JGC – PersonEntity: Name: NameFull: Crombag MR – PersonEntity: Name: NameFull: Dumoulin D – PersonEntity: Name: NameFull: Hendrikx JJMA – PersonEntity: Name: NameFull: Theelen W – PersonEntity: Name: NameFull: van der Hulle T – PersonEntity: Name: NameFull: Kapiteijn E – PersonEntity: Name: NameFull: Zwaveling J – PersonEntity: Name: NameFull: Becker A – PersonEntity: Name: NameFull: Hiltermann J – PersonEntity: Name: NameFull: Hendriks LEL – PersonEntity: Name: NameFull: van Geel RMJM – PersonEntity: Name: NameFull: van Geffen WH – PersonEntity: Name: NameFull: van den Heuvel M – PersonEntity: Name: NameFull: Oude Munnink TH – PersonEntity: Name: NameFull: Smit EF – PersonEntity: Name: NameFull: Guchelaar HJ – PersonEntity: Name: NameFull: Moes DJAR – PersonEntity: Name: NameFull: Ter Heine R IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 05 Text: 2026 May 23 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1879-0852 Numbering: – Type: volume Value: 243 Titles: – TitleFull: European journal of cancer (Oxford, England : 1990) Type: main |
| ResultId | 1 |